FDA Warns of Acetaminophen Toxicity Risk From Doubling Dosing

Federal health officials are warning consumers battling the flu to be aware that many medications contain acetaminophen and they may face a risk of severe liver damage from acetaminophen toxicity if they take multiple drugs containing the painkiller or take more than the recommended daily dose.

In a consumer update posted to the FDA’s website this week, the agency warns individuals not to “double up” on flu medications, many of which contain acetaminophen. Doing so can potentially lead to an acetaminophen overdose, placing the liver at risk of severe injury that may result in the need for a transplant or cause death.

More than 600 medications, both prescription and over-the-counter, contain acetaminophen, the FDA warns. Quite often, particularly during the cold and flu season, consumers take multiple medications to alleviate symptoms without realizing how much acetaminophen they are actually taking.

Tylenol Autism Lawsuit

Does your child have Austism from Tylenol Exposure?

Side effects of Tylenol may cause autism and ADHD among children exposed during pregnancy. Find out if your family may be eligible for a Tylenol autism or ADHD settlement.

Learn More See If You Qualify For Compensation

The current maximum daily dose of acetaminophen for an adult should not exceed 4,000 milligrams per day, according to FDA recommendations.

The agency gave the following tips to avoid a acetaminophen toxicity:

  • Don’t take more than one over-the-counter drug that contains acetaminophen
  • Don’t take an over-the-counter drug with a prescription drug that both contain acetaminophen
  • Don’t exceed the recommended dose on any drug that contains acetaminophen

The FDA also recommends that consumers tell their doctor and pharmacist what other drugs they are taking when being prescribed medication or when buying it over-the counter, and to check the label and ask about acetaminophen in new drugs they begin taking. The FDA has published a list of brand name drugs that contain acetaminophen.

According to the FDA, acetaminophen toxicity is a leading cause of liver failure in the U.S., resulting in more than 50,000 emergency room visits, 25,000 hospitalizations and over 450 deaths annually.  In a 2002 FDA advisory committee meeting, experts found that there were between 1,000 and 2,000 acetaminophen-induced liver failures each year.

In recent years, a growing number of individuals throughout the United States have filed an acetaminophen liver failure lawsuit against Johnson & Johnson, alleging that the drug maker failed to provide adequate warnings about the potential side effects of Tylenol, which is one of the leading pain medications in the world.

In July 2011, Johnson & Johnson announced that it was lowering the maximum recommended dosage on Tylenol and other acetaminophen-based products from 4,000 mg per day to 3,000 mg per day. The decision came after the FDA announced new limits on acetaminophen levels in prescription painkillers like Vicodin and Percocet. But over-the-counter painkillers and drugs with acetaminophen went unaffected.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure
Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure (Posted today)

Lawyers have reached a confidential settlement agreement to resolve tens of thousands of Bard hernia mesh lawsuits after six years of litigation, but individuals must still agree to participate and settle their claims.

Class Action Claims Over Hair Relaxer Risks Cleared To Move Forward by MDL Judge
Class Action Claims Over Hair Relaxer Risks Cleared To Move Forward by MDL Judge (Posted yesterday)

Court rejected a motion to dismiss the hair relaxer class actions lawsuits, which seek economic damages for consumers exposed to toxic chemicals in the products, which are now known to increase the risk of uterine cancer, ovarian cancer and other injuries.